IRADIMED CORP Quarterly Liabilities, Current in USD from Q4 2013 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Iradimed Corp quarterly Liabilities, Current history and growth rate from Q4 2013 to Q4 2024.
Iradimed Corp Liabilities, Current for the quarter ending December 31, 2024 was $8.51M, a 47.9% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$8.51M	-$7.81M	-47.9%	Dec 31, 2024	10-K	2025-03-06
Q3 2024	$8.06M	+$181K	+2.3%	Sep 30, 2024	10-Q	2024-10-31
Q2 2024	$7.46M	-$127K	-1.68%	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$7.62M	+$861K	+12.7%	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$16.3M	+$7.77M	+90.9%	Dec 31, 2023	10-K	2025-03-06
Q3 2023	$7.88M	+$2.28M	+40.7%	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$7.59M	+$1.45M	+23.6%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$6.76M	+$507K	+8.11%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$8.55M	+$1.73M	+25.4%	Dec 31, 2022	10-K	2024-03-01
Q3 2022	$5.6M	-$717K	-11.3%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$6.14M	-$159K	-2.53%	Jun 30, 2022	10-Q	2022-08-05
Q1 2022	$6.25M	+$1.61M	+34.8%	Mar 31, 2022	10-Q	2022-05-06
Q4 2021	$6.82M	+$1.91M	+38.8%	Dec 31, 2021	10-K	2023-03-02
Q3 2021	$6.32M	+$1.56M	+32.8%	Sep 30, 2021	10-Q	2021-11-05
Q2 2021	$6.3M	+$1.04M	+19.8%	Jun 30, 2021	10-Q	2021-08-06
Q1 2021	$4.63M	-$246K	-5.04%	Mar 31, 2021	10-Q	2021-05-07
Q4 2020	$4.92M	-$942K	-16.1%	Dec 31, 2020	10-K	2022-03-04
Q3 2020	$4.76M	-$893K	-15.8%	Sep 30, 2020	10-Q	2020-11-06
Q2 2020	$5.25M	+$397K	+8.18%	Jun 30, 2020	10-Q	2020-08-06
Q1 2020	$4.88M	-$125K	-2.51%	Mar 31, 2020	10-Q	2020-05-07
Q4 2019	$5.86M	+$1.17M	+24.9%	Dec 31, 2019	10-K	2021-03-05
Q3 2019	$5.65M	+$860K	+17.9%	Sep 30, 2019	10-Q	2019-11-07
Q2 2019	$4.86M	+$216K	+4.66%	Jun 30, 2019	10-Q	2019-08-07
Q1 2019	$5.01M	+$1.06M	+27%	Mar 31, 2019	10-Q	2019-05-08
Q4 2018	$4.69M	+$612K	+15%	Dec 31, 2018	10-K	2020-03-06
Q3 2018	$4.79M	+$943K	+24.5%	Sep 30, 2018	10-Q	2018-11-07
Q2 2018	$4.64M	+$1.01M	+27.8%	Jun 30, 2018	10-Q	2018-08-08
Q1 2018	$3.94M	+$321K	+8.88%	Mar 31, 2018	10-Q	2018-05-08
Q4 2017	$4.08M	+$416K	+11.4%	Dec 31, 2017	10-K	2019-03-07
Q3 2017	$3.85M	+$467K	+13.8%	Sep 30, 2017	10-Q	2017-11-06
Q2 2017	$3.63M	+$731K	+25.2%	Jun 30, 2017	10-Q	2017-08-04
Q1 2017	$3.62M	+$14.9K	+0.41%	Mar 31, 2017	10-Q	2017-05-05
Q4 2016	$3.66M	+$774K	+26.8%	Dec 31, 2016	10-K	2018-03-08
Q3 2016	$3.38M	+$713K	+26.7%	Sep 30, 2016	10-Q	2016-11-04
Q2 2016	$2.9M	-$631K	-17.9%	Jun 30, 2016	10-Q	2016-08-05
Q1 2016	$3.6M	+$726K	+25.2%	Mar 31, 2016	10-Q	2016-05-06
Q4 2015	$2.89M	+$612K	+26.9%	Dec 31, 2015	10-K	2017-03-10
Q3 2015	$2.67M	+$571K	+27.2%	Sep 30, 2015	10-Q	2015-11-10
Q2 2015	$3.53M	+$1.03M	+41.3%	Jun 30, 2015	10-Q	2015-08-11
Q1 2015	$2.88M			Mar 31, 2015	10-Q	2015-05-11
Q4 2014	$2.28M	+$824K	+56.7%	Dec 31, 2014	10-K	2016-03-10
Q3 2014	$2.1M			Sep 30, 2014	10-Q	2014-11-13
Q2 2014	$2.5M			Jun 30, 2014	10-Q	2014-08-14
Q4 2013	$1.45M			Dec 31, 2013	10-K	2015-03-23

Previous1Next

Showing 1 to 44 of 44 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.